These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 31874447

  • 1. Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer.
    Wang J, Ni J, Beretov J, Thompson J, Graham P, Li Y.
    Crit Rev Oncol Hematol; 2020 Jan; 145():102860. PubMed ID: 31874447
    [Abstract] [Full Text] [Related]

  • 2. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
    Valentino A, Reclusa P, Sirera R, Giallombardo M, Camps C, Pauwels P, Crispi S, Rolfo C.
    Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
    [Abstract] [Full Text] [Related]

  • 3. Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker.
    Piao XM, Cha EJ, Yun SJ, Kim WJ.
    Int J Mol Sci; 2021 Feb 08; 22(4):. PubMed ID: 33567779
    [Abstract] [Full Text] [Related]

  • 4. The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer.
    de Nóbrega M, Dos Reis MB, Pereira ÉR, de Souza MF, de Syllos Cólus IM.
    J Cancer Res Clin Oncol; 2022 Oct 08; 148(10):2893-2910. PubMed ID: 35922694
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous multiplexed detection of exosomal microRNAs and surface proteins for prostate cancer diagnosis.
    Cho S, Yang HC, Rhee WJ.
    Biosens Bioelectron; 2019 Dec 15; 146():111749. PubMed ID: 31600625
    [Abstract] [Full Text] [Related]

  • 6. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.
    Foj L, Ferrer F, Serra M, Arévalo A, Gavagnach M, Giménez N, Filella X.
    Prostate; 2017 May 15; 77(6):573-583. PubMed ID: 27990656
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.
    Endzeliņš E, Melne V, Kalniņa Z, Lietuvietis V, Riekstiņa U, Llorente A, Linē A.
    Mol Cancer; 2016 May 18; 15(1):41. PubMed ID: 27189160
    [Abstract] [Full Text] [Related]

  • 8. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
    Barceló M, Castells M, Bassas L, Vigués F, Larriba S.
    Sci Rep; 2019 Sep 24; 9(1):13772. PubMed ID: 31551516
    [Abstract] [Full Text] [Related]

  • 9. Exosomal noncoding RNAs in prostate cancer.
    Movahedpour A, Khatami SH, Karami N, Vakili O, Naeli P, Jamali Z, Shabaninejad Z, Tazik K, Behrouj H, Ghasemi H.
    Clin Chim Acta; 2022 Dec 01; 537():127-132. PubMed ID: 36330945
    [Abstract] [Full Text] [Related]

  • 10. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers.
    Filella X, Foj L.
    Int J Mol Sci; 2016 Oct 26; 17(11):. PubMed ID: 27792187
    [Abstract] [Full Text] [Related]

  • 11. Emerging Role of Exosomes in Liquid Biopsy for Monitoring Prostate Cancer Invasion and Metastasis.
    Gao Z, Pang B, Li J, Gao N, Fan T, Li Y.
    Front Cell Dev Biol; 2021 Oct 26; 9():679527. PubMed ID: 34017837
    [Abstract] [Full Text] [Related]

  • 12. Liquid biopsy: Exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer.
    Preethi KA, Selvakumar SC, Ross K, Jayaraman S, Tusubira D, Sekar D.
    Mol Cancer; 2022 Feb 16; 21(1):54. PubMed ID: 35172817
    [Abstract] [Full Text] [Related]

  • 13. Emerging role of exosomes as biomarkers in cancer treatment and diagnosis.
    Hanjani NA, Esmaelizad N, Zanganeh S, Gharavi AT, Heidarizadeh P, Radfar M, Omidi F, MacLoughlin R, Doroudian M.
    Crit Rev Oncol Hematol; 2022 Jan 16; 169():103565. PubMed ID: 34871719
    [Abstract] [Full Text] [Related]

  • 14. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
    Wang YH, Ji J, Wang BC, Chen H, Yang ZH, Wang K, Luo CL, Zhang WW, Wang FB, Zhang XL.
    Cell Physiol Biochem; 2018 Jan 16; 46(2):532-545. PubMed ID: 29614511
    [Abstract] [Full Text] [Related]

  • 15. MiR-375 and miR-21 as Potential Biomarkers of Prostate Cancer: Comparison of Matching Samples of Plasma and Exosomes.
    Joković SM, Dobrijević Z, Kotarac N, Filipović L, Popović M, Korać A, Vuković I, Savić-Pavićević D, Brajušković G.
    Genes (Basel); 2022 Dec 09; 13(12):. PubMed ID: 36553586
    [Abstract] [Full Text] [Related]

  • 16. Exosomal Prostate-Specific Membrane Antigen (PSMA) and Caveolin-1 as Potential Biomarkers of Prostate Cancer-Evidence from Serbian Population.
    Matijašević Joković S, Korać A, Kovačević S, Djordjević A, Filipović L, Dobrijević Z, Brkušanin M, Savić-Pavićević D, Vuković I, Popović M, Brajušković G.
    Int J Mol Sci; 2024 Mar 21; 25(6):. PubMed ID: 38542507
    [Abstract] [Full Text] [Related]

  • 17. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
    Salido-Guadarrama AI, Morales-Montor JG, Rangel-Escareño C, Langley E, Peralta-Zaragoza O, Cruz Colin JL, Rodriguez-Dorantes M.
    Mol Med Rep; 2016 Jun 21; 13(6):4549-60. PubMed ID: 27081843
    [Abstract] [Full Text] [Related]

  • 18. The Potential of MicroRNAs as Prostate Cancer Biomarkers.
    Fabris L, Ceder Y, Chinnaiyan AM, Jenster GW, Sorensen KD, Tomlins S, Visakorpi T, Calin GA.
    Eur Urol; 2016 Aug 21; 70(2):312-22. PubMed ID: 26806656
    [Abstract] [Full Text] [Related]

  • 19. Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis.
    Pang B, Zhu Y, Ni J, Thompson J, Malouf D, Bucci J, Graham P, Li Y.
    Theranostics; 2020 Aug 21; 10(5):2309-2326. PubMed ID: 32089744
    [Abstract] [Full Text] [Related]

  • 20. Clinical utility of emerging biomarkers in prostate cancer liquid biopsies.
    Boerrigter E, Groen LN, Van Erp NP, Verhaegh GW, Schalken JA.
    Expert Rev Mol Diagn; 2020 Feb 21; 20(2):219-230. PubMed ID: 31577907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.